Betaserc tablet 24 mg: The dosage for adults is 48 mg divided over the day.
24 mg: 1 tablet 2 times/day.
The dosage should be individually adapted according to the response. Improvement can sometimes only be observed after a couple of weeks of treatment. The best results are sometimes obtained after a few months. There are indications that treatment from the onset of the disease prevents the progression of the disease and/or the loss of hearing in later phases of the disease.
Paediatric population: Betaserc is not recommended for use in children below 18 years due to insufficient data on safety and efficacy.
Geriatric population: Although there are limited data from clinical studies in this patient group, extensive post-marketing experience suggests that no dose adjustment is necessary in this patient population.
Renal impairment: There are no specific clinical trials available in this patient group, but according to post-marketing experience no dose adjustment appears to be necessary.
Hepatic impairment: There are no specific clinical trials available in this patient group, but according to post-marketing experience no dose adjustment appears to be necessary.
Method of Administration: Should be swallowed with water.